Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1.
about
Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteinsDetection of HTLV-I and -II in Scottish blood donor samples and archive donations.Multiple functions for the basic amino acids of the human T-cell leukemia virus type 1 matrix protein in viral transmissionThe conserved glycine-rich segment linking the N-terminal fusion peptide to the coiled coil of human T-cell leukemia virus type 1 transmembrane glycoprotein gp21 is a determinant of membrane fusion function.Oversight and monitoring of blood safety in the United States.Screening for human T cell leukaemia/lymphoma virus among blood donors in Sweden: cost effectiveness analysis.Viral inactivation of fresh frozen plasma.Leucocyte depletion of the blood supply - how will patients benefit?Estimating per-act HIV transmission risk: a systematic review.Human T Lymphotropic Virus Type 1 (HTLV-1): Molecular Biology and Oncogenesis.The ectodomain of the human T-cell leukemia virus type 1 TM glycoprotein is involved in postfusion events.Milk sharing and formula feeding: Infant feeding risks in comparative perspective?Crystallization of a trimeric human T cell leukemia virus type 1 gp21 ectodomain fragment as a chimera with maltose-binding protein.Pathways of cell-cell transmission of HTLV-1Prevalence of Human T Cell Leukaemia Virus amongst Blood Donors.Human T cell leukaemia/lymphoma virus infection in pregnant women in the United Kingdom: population study.Seroprevalence and demographic determinants of human T-lymphotropic virus type 1 and 2 infections among first-time blood donors--United States, 2000-2009.Human T-lymphotropic virus and transfusion safety: does one size fit all?Homogenous HIV-1 subtype B quasispecies in Brazilian men and women recently infected via heterosexual transmission.Analysis of functional conservation in the surface and transmembrane glycoprotein subunits of human T-cell leukemia virus type 1 (HTLV-1) and HTLV-2.The Y-S-L-I tyrosine-based motif in the cytoplasmic domain of the human T-cell leukemia virus type 1 envelope is essential for cell-to-cell transmission.Cell-free HTLV-1 infects dendritic cells leading to transmission and transformation of CD4(+) T cells.Neuropilin-1 is involved in human T-cell lymphotropic virus type 1 entry.Reconsideration of blood donation testing strategy for human T-cell lymphotropic virus in Australia.Cloaked virus slips between cellsSimian foamy virus infection by whole-blood transfer in rhesus macaques: potential for transfusion transmission in humans.Evidence that the transmembrane domain proximal region of the human T-cell leukemia virus type 1 fusion glycoprotein gp21 has distinct roles in the prefusion and fusion-activated states.HTLV-1-associated myelopathy/tropical spastic paraparesis.Human T-lymphotropic virus lookback in NHS Blood and Transplant (England) reveals the efficacy of leukoreduction.Effectiveness of human T-lymphotropic virus (HTLV) recipient tracing (lookback) and the current HTLV-I and -II confirmatory algorithm, 1999 to 2004.Simian foamy virus infection in a blood donor.Human T-cell lymphotrophic virus infection in organ donors: a need to reassess policy?Risk management in blood transfusion services.The RADAR repository: a resource for studies of infectious agents and their transmissibility by transfusion.Temporal trends in Human T-Lymphotropic virus 1 (HTLV-1) associated myelopathy/tropical spastic paraparesis (HAM/TSP) incidence in Martinique over 25 years (1986-2010).Cost-effectiveness of solvent/detergent-treated fresh-frozen plasma.Photodynamic sterilization of red cells and its effect on contaminating white cells: viability and mechanism of cell death.Evaluation of HTLV-I removal by filtration of blood cell components in a routine setting.The HTLV-1 gp21 fusion peptide inhibits antigen specific T-cell activation in-vitro and in mice.Quality control of leucoreduced cellular blood components in France
P2860
Q27617901-3151EAF8-F71A-484A-96ED-87D75E8B82E4Q33256730-DE805FE9-866F-48F5-8335-C73FDD78148DQ33652796-11FF0997-7971-44BF-AF14-F1B49FF1EB1DQ33707457-49F19F49-F7C9-4991-8CC9-263371C31D51Q33749419-E411BF84-2C30-4FEA-923C-7B355CE8000AQ33786062-D7150213-D43F-4A63-A6EA-A31E732E3969Q33992794-0FE1D34A-AD1A-469E-9ED4-30ADD3CC042CQ34022474-822EDFA2-CE46-4241-9886-DDB2D3DAD86AQ34661804-EBF7B09D-7C15-4AB8-8E9E-66F37FD6805DQ35261245-8DF47376-7123-4824-A635-F7B82501DFE6Q35894677-761BBB95-528B-4EC7-9C7F-75E9CA26C698Q36090866-9475F94F-A5C6-4F5D-9166-34239EBB32E3Q36281087-38C51E56-47B5-4CF4-9722-7CD4F5F989E8Q36343823-A95FD535-D3B8-459E-8D92-F96B797F7BF8Q37039008-29F95007-CB51-48D6-AA98-CE56C7691849Q37335623-5996B0FA-0925-4CDF-A8AA-DBF0F8D3DD2DQ37520190-2E6D08C8-E6AC-436F-A6BA-4E6F34909B91Q38590004-7EE77980-4EA6-47AA-B09A-8ABF7F2954D7Q39250937-A818CBB7-6B1F-44F2-8FC4-B5CA864E3BEFQ39580518-993B1EF6-9C77-41B1-B53D-2085EEFBBFCCQ39596731-DBDEF491-0048-4776-91AC-2E58232FECA7Q39996982-EE29E0C6-15E4-4A56-8A54-761185C9C216Q41494007-3207E0B2-2AD1-4FBB-9FA2-8D16DB86BB7FQ41928215-C33ED32C-24E8-487C-9CDB-CB363836BA32Q42557998-3EC630FA-5B9C-4D69-81A2-E13127972012Q43221224-EE711883-F03A-496C-A6B0-3AE0CF9D7741Q43763067-1B6C2811-CD79-464F-9D99-93CF8182A6E8Q45096240-C5B62926-69E4-4E5B-9F2C-4D8656EF3F4FQ45352770-B424CDBF-D464-4D07-B2AD-639F95DB39B8Q45416892-8BD01970-629D-4A61-B22A-9E60F1BF4407Q45730499-D89118BC-836B-4285-BA01-6BEA31E7E4E0Q45731173-27551446-0EAE-41F2-A3D8-8F2CAEB17E7EQ47752466-0356D345-914F-4DAC-902D-EC86CCFD7D82Q50762268-907711CD-8768-447E-9088-DA87A8EA1338Q51738503-8173A8CD-E4E7-4B42-B65B-DC8AC582D972Q52010790-08BEB8A5-FA71-4F34-BAD9-44C6ECA49A91Q54091354-C098A0FD-AAAE-4FBA-9726-5E4A7965D369Q54736313-A8C57103-E8C3-4BCC-9407-07CE027FA0C8Q54957634-34BC7F25-FBE5-453C-886C-B2DD1AF18EADQ56833964-E4B4681E-468F-4233-89AC-4CA487CACF30
P2860
Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type 1.
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年学术文章
@wuu
1994年学术文章
@zh
1994年学术文章
@zh-cn
1994年学术文章
@zh-hans
1994年学术文章
@zh-my
1994年学术文章
@zh-sg
1994年學術文章
@yue
1994年學術文章
@zh-hant
name
Transfusion transmission of re ...... immunodeficiency virus type 1.
@en
Transfusion transmission of re ...... immunodeficiency virus type 1.
@nl
type
label
Transfusion transmission of re ...... immunodeficiency virus type 1.
@en
Transfusion transmission of re ...... immunodeficiency virus type 1.
@nl
prefLabel
Transfusion transmission of re ...... immunodeficiency virus type 1.
@en
Transfusion transmission of re ...... immunodeficiency virus type 1.
@nl
P2093
P1433
P1476
Transfusion transmission of re ...... immunodeficiency virus type 1.
@en
P2093
Hollingsworth CG
Kleinman SH
Nowicki MJ
Operskalski EA
Stevens CE
P304
P356
10.1046/J.1537-2995.1994.34694295061.X
P577
1994-06-01T00:00:00Z